These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

624 related articles for article (PubMed ID: 29865233)

  • 1. Current Knowledge on Endocrine Disrupting Chemicals (EDCs) from Animal Biology to Humans, from Pregnancy to Adulthood: Highlights from a National Italian Meeting.
    Street ME; Angelini S; Bernasconi S; Burgio E; Cassio A; Catellani C; Cirillo F; Deodati A; Fabbrizi E; Fanos V; Gargano G; Grossi E; Iughetti L; Lazzeroni P; Mantovani A; Migliore L; Palanza P; Panzica G; Papini AM; Parmigiani S; Predieri B; Sartori C; Tridenti G; Amarri S
    Int J Mol Sci; 2018 Jun; 19(6):. PubMed ID: 29865233
    [TBL] [Abstract][Full Text] [Related]  

  • 2. New insights on the effects of endocrine-disrupting chemicals on children.
    Predieri B; Alves CAD; Iughetti L
    J Pediatr (Rio J); 2022; 98 Suppl 1(Suppl 1):S73-S85. PubMed ID: 34921754
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Endocrine Disrupting Chemicals' Effects in Children: What We Know and What We Need to Learn?
    Predieri B; Iughetti L; Bernasconi S; Street ME
    Int J Mol Sci; 2022 Oct; 23(19):. PubMed ID: 36233201
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Clinical epidemiology studies on potential effects of endocrine disrupting chemicals (EDCs) should exclude subjects with obesity as determined by BMI.
    Smith CJ; Perfetti TA; Hayes AW; Berry SC
    Regul Toxicol Pharmacol; 2020 Aug; 115():104711. PubMed ID: 32598900
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Obesogens: an emerging threat to public health.
    Janesick AS; Blumberg B
    Am J Obstet Gynecol; 2016 May; 214(5):559-65. PubMed ID: 26829510
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Endocrine-disrupting chemicals and child health.
    Kiess W; Häussler G; Vogel M
    Best Pract Res Clin Endocrinol Metab; 2021 Sep; 35(5):101516. PubMed ID: 33773932
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The Role of Epigenetics in the Latent Effects of Early Life Exposure to Obesogenic Endocrine Disrupting Chemicals.
    Stel J; Legler J
    Endocrinology; 2015 Oct; 156(10):3466-72. PubMed ID: 26241072
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Fifteen years after "Wingspread"--environmental endocrine disrupters and human and wildlife health: where we are today and where we need to go.
    Hotchkiss AK; Rider CV; Blystone CR; Wilson VS; Hartig PC; Ankley GT; Foster PM; Gray CL; Gray LE
    Toxicol Sci; 2008 Oct; 105(2):235-59. PubMed ID: 18281716
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Epigenetic modifications associated with in utero exposure to endocrine disrupting chemicals BPA, DDT and Pb.
    Onuzulu CD; Rotimi OA; Rotimi SO
    Rev Environ Health; 2019 Dec; 34(4):309-325. PubMed ID: 31271561
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Human exposure to synthetic endocrine disrupting chemicals (S-EDCs) is generally negligible as compared to natural compounds with higher or comparable endocrine activity. How to evaluate the risk of the S-EDCs?
    Autrup H; Barile FA; Berry SC; Blaauboer BJ; Boobis A; Bolt H; Borgert CJ; Dekant W; Dietrich D; Domingo JL; Gori GB; Greim H; Hengstler J; Kacew S; Marquardt H; Pelkonen O; Savolainen K; Heslop-Harrison P; Vermeulen NP
    Chem Biol Interact; 2020 Aug; 326():109099. PubMed ID: 32370863
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Human exposure to synthetic endocrine disrupting chemicals (S-EDCs) is generally negligible as compared to natural compounds with higher or comparable endocrine activity: how to evaluate the risk of the S-EDCs?
    Autrup H; Barile FA; Berry SC; Blaauboer BJ; Boobis A; Bolt H; Borgert CJ; Dekant W; Dietrich D; Domingo JL; Gori GB; Greim H; Hengstler J; Kacew S; Marquardt H; Pelkonen O; Savolainen K; Heslop-Harrison P; Vermeulen NP
    Arch Toxicol; 2020 Jul; 94(7):2549-2557. PubMed ID: 32514609
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The molecular mechanisms of action of the endocrine disrupting chemical bisphenol A in the development of cancer.
    Shafei A; Ramzy MM; Hegazy AI; Husseny AK; El-Hadary UG; Taha MM; Mosa AA
    Gene; 2018 Mar; 647():235-243. PubMed ID: 29317319
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Endocrine-Disrupting Chemicals and Their Effects during Female Puberty: A Review of Current Evidence.
    Lucaccioni L; Trevisani V; Marrozzini L; Bertoncelli N; Predieri B; Lugli L; Berardi A; Iughetti L
    Int J Mol Sci; 2020 Mar; 21(6):. PubMed ID: 32197344
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Epigenetic Modifications Associated with Exposure to Endocrine Disrupting Chemicals in Patients with Gestational Diabetes Mellitus.
    Kunysz M; Mora-Janiszewska O; Darmochwał-Kolarz D
    Int J Mol Sci; 2021 Apr; 22(9):. PubMed ID: 33946662
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Male pubertal development: are endocrine-disrupting compounds shifting the norms?
    Zawatski W; Lee MM
    J Endocrinol; 2013; 218(2):R1-12. PubMed ID: 23709001
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Placenta Disrupted: Endocrine Disrupting Chemicals and Pregnancy.
    Gingrich J; Ticiani E; Veiga-Lopez A
    Trends Endocrinol Metab; 2020 Jul; 31(7):508-524. PubMed ID: 32249015
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Possible relationship between endocrine disrupting chemicals and hormone dependent gynecologic cancers.
    Dogan S; Simsek T
    Med Hypotheses; 2016 Jul; 92():84-7. PubMed ID: 27241264
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Environmental Endocrine-Disrupting Chemical Exposure: Role in Non-Communicable Diseases.
    Kumar M; Sarma DK; Shubham S; Kumawat M; Verma V; Prakash A; Tiwari R
    Front Public Health; 2020; 8():553850. PubMed ID: 33072697
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Endocrine disrupting chemicals and growth of children.
    Botton J; Kadawathagedara M; de Lauzon-Guillain B
    Ann Endocrinol (Paris); 2017 Jun; 78(2):108-111. PubMed ID: 28483365
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Deleterious Biological Effects of Endocrine Disruptors: An Insight into Human Health Risks.
    Al Lawati A; Al Hashmi L; Al Aswami H; Al Hadhrami A; Chin KY; Sirasanagandla SR; Das S
    Endocr Metab Immune Disord Drug Targets; 2024; 24(13):1471-1479. PubMed ID: 38299284
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 32.